Shares of Acasti Pharma (NASDAQ:ACST) are jumping more than 25% higher today after a major investment firm initiated coverage. ACST stock has declined by more than 50% year to date (YTD), vastly ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Acasti Pharma (ACST) is a stock that can certainly grab the ...

Acasti Pharma (ACST) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

The market has been volatile in the last few months as the Federal Reserve finalized its rate cuts and uncertainty looms over trade negotiations with China. Small cap stocks have been hit hard as a ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and end-of-month settlement dates. It is then released ...